Concurrent rectal perforation and obstruction following neoadjuvant chemoradiation for locally advanced rectal cancer: A case report

被引:0
|
作者
Tahouri, Tahmineh [1 ]
Omami, Sahand Hedayati [2 ]
Hosseini, Maryam [3 ]
Rahimi-Movaghar, Ehsanollah [4 ,5 ]
机构
[1] Shahid Beheshti Univ Med Sci, Shahid Modarres Educ Hosp, Pediat Cardiol, Tehran, Iran
[2] Azad Univ, Farhikhtegan Hosp, Sch Med, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci & Hlth Serv, Taleghani Hosp, Shahid Chamran Highway,Yemen St, Tehran, Iran
[4] Islamic Azad Univ, Farhikhtegan Hosp, Fac Med, Dept Surg,Tehran Med Sci, Tehran, Iran
[5] Farhikhtegan Hosp, Shohadaye Hesarak Blvd, Tehran, Iran
来源
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS | 2024年 / 116卷
关键词
Rectal cancer; Rectal cancers; Intestinal perforation; Intestinal obstruction; Adjuvant radiotherapy; Case report; RADIATION-THERAPY;
D O I
10.1016/j.ijscr.2024.109337
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: Locally advanced rectal cancer (LARC) is commonly managed with neoadjuvant chemoradiation (neoCRT) followed by surgery, though not without complications. The anatomical exposure of the colon and rectum and pelvic radiotherapy poses risk, with rectal perforation and bowel obstruction, though rare, carrying life-threatening potential. Presentation of case: This case highlights an exceptionally rare occurrence of concurrent rectal perforation and rectal obstruction in a 77-year-old male with LARC, just two months post neoCRT. Initial symptoms included rectal bleeding, and diagnostic procedures confirmed rectal T1N3adenocarcinoma with no metastasis. Emergency admission, prompted by complete bowel obstruction symptoms, led to discovery of rectal perforation during laparotomy, sealed by the bladder. Pathological analysis attributed the cause to radiation proctitis, reporting complete response to neoCRT with no residual tumor. Discussion: The rarity of both bowel obstruction and perforation as neoCRT complications, particularly in the acute phase of radiation proctitis, is noteworthy in this case. The absence of tumoral cells at the affected sites emphasizes the exceptional nature of this case. Conclusion: This case underscores the importance of recognizing acute post neoCRT injuries as potentially lifethreatening complications, emphasizing the need for heightened awareness and consideration in clinical management.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Validation of the Neoadjuvant Rectal Cancer (NAR) Score for Prognostication Following Total Neoadjuvant Therapy (TNT) for Locally Advanced Rectal Cancer
    Shivani Shah
    Palash Asawa
    Stephen Abel
    Rodney E. Wegner
    Journal of Gastrointestinal Cancer, 2023, 54 : 829 - 836
  • [22] Neoadjuvant treatment for locally advanced rectal cancer: a systematic review
    Uehara, Keisuke
    Nagino, Masato
    SURGERY TODAY, 2016, 46 (02) : 161 - 168
  • [23] Predicting the pathological response to neoadjuvant chemoradiation using untargeted metabolomics in locally advanced rectal cancer
    Jia, Huixun
    Shen, Xiaotao
    Guan, Yun
    Xu, Meimei
    Tu, Jia
    Mo, Miao
    Xie, Li
    Yuan, Jing
    Zhang, Zhen
    Cai, Sanjun
    Zhu, Ji
    Zhu, ZhengJiang
    RADIOTHERAPY AND ONCOLOGY, 2018, 128 (03) : 548 - 556
  • [24] The significance of mucin pools following neoadjuvant chemoradiotherapy for locally advanced rectal cancer
    Reynolds, Ian S.
    McNamara, Deborah A.
    Kay, Elaine W.
    O'Neill, Brian
    Deasy, Joseph
    Burke, John P.
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 118 (07) : 1129 - 1134
  • [25] Impact of PET/CT for Restaging Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation
    Sorenson, Eric
    Lambreton, Fernando
    Yu, Jian Q.
    Li, Tianyu
    Denlinger, Crystal S.
    Meyer, Joshua E.
    Sigurdson, Elin R.
    Farma, Jeffrey M.
    JOURNAL OF SURGICAL RESEARCH, 2019, 243 : 242 - 248
  • [26] Role of Oxaliplatin in the Neoadjuvant Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: a Review of Evidence
    Nazari, Reza
    Piozzi, Guglielmo Niccolo
    Ghalehtaki, Reza
    Ahmadi-Tafti, Seyed Mohsen
    Behboudi, Behnam
    Darzikolaee, Nima Mousavi
    Aghili, Mahdi
    Gambacorta, Maria Antonietta
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2024, 18
  • [27] Locally advanced rectal cancer receiving total neoadjuvant therapy combined with nivolumab: a case report and literature review
    Mori, Ryota
    Uemura, Mamoru
    Sekido, Yuki
    Hata, Tsuyoshi
    Ogino, Takayuki
    Takahashi, Hidekazu
    Miyoshi, Norikatsu
    Mizushima, Tsunekazu
    Doki, Yuichiro
    Eguchi, Hidetoshi
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [28] Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial
    Bazarbashi, Shouki
    Elshenawy, Mahmoud A.
    Badran, Ahmed
    Aljubran, Ali
    Alzahrani, Ahmed
    Almanea, Hadeel
    Alsuhaibani, Abdullah
    Alashwah, Ahmed
    Neimatallah, Mohamed
    Abduljabbar, Alaa
    Ashari, Luai
    Alhomoud, Samar
    Ghebeh, Hazem
    Elhassan, Tusneem
    Alsanea, Nasser
    Mohiuddin, Mohammed
    CANCER MEDICINE, 2022, 11 (10): : 2056 - 2066
  • [29] Current Controversies in Neoadjuvant Chemoradiation of Rectal Cancer
    Phang, P. Terry
    Wang, Xiaodong
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 23 (01) : 79 - +
  • [30] Total neoadjuvant treatment in locally advanced rectal cancer
    De Felice, Francesca
    Tombolini, Vincenzo
    Cortesi, Enrico
    TRANSLATIONAL ONCOLOGY, 2021, 14 (05):